CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Total Revenue		$ 10,790	$ 14,248	$ 43,403	$ 36,934
Cost of goods sold		(2,868)	(3,205)	(8,121)	(7,945)
Research and development expenses, net	[1]	(7,688)	(10,000)	(27,214)	(35,021)
Selling, general and administrative expenses	[2]	(2,816)	(2,587)	(8,197)	(6,885)
OPERATING LOSS		(2,582)	(1,544)	(129)	(12,917)
Financial expenses		(1,973)	(2,050)	(7,150)	(5,877)
Financial income		118	34	359	227
Financial expenses, net		(1,855)	(2,016)	(6,791)	(5,650)
Net loss for the period		$ (4,437)	$ (3,560)	$ (6,920)	$ (18,567)
Loss per share of common stock - Basic and diluted		$ (0.14)	$ (0.24)	$ (0.25)	$ (1.25)
Weighted average number of shares of common stock used in computing loss per share - basic and diluted		32,863,788	14,838,213	27,758,104	14,838,213
Goods [Member]
Total Revenue		$ 3,296	$ 5,126	$ 11,975	$ 12,086
License and R&D Services [Member]
Total Revenue		$ 7,494	$ 9,122	$ 31,428	$ 24,848

[1] (1) Includes share-based compensation

[2] (2) Includes share-based compensation